In-Vitro Diagnostics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of In-Vitro Diagnostics Market
1.1. Definition and Scope
1.1.1. Definition of In-Vitro Diagnostics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global In-Vitro Diagnostics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. In-Vitro Diagnostics Market By Product
1.2.3. In-Vitro Diagnostics Market By Technology
1.2.4. In-Vitro Diagnostics Market By Application
1.2.5. In-Vitro Diagnostics Market By End-Use
1.2.6. In-Vitro Diagnostics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of In-Vitro Diagnostics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for In-Vitro Diagnostics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. In-Vitro Diagnostics Market By Product
5.1. Introduction
5.2. In-Vitro Diagnostics Revenue By Product
5.2.1. In-Vitro Diagnostics Revenue (USD Billion) and Forecast, By Product, 2018-2030
5.2.2. Instruments
5.2.2.1. Instruments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Reagents
5.2.3.1. Reagents Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Services
5.2.4.1. Services Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. In-Vitro Diagnostics Market By Technology
6.1. Introduction
6.2. In-Vitro Diagnostics Revenue By Technology
6.2.1. In-Vitro Diagnostics Revenue (USD Billion) and Forecast, By Technology, 2018-2030
6.2.2. Immunoassay
6.2.2.1. Immunoassay Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Hematology
6.2.3.1. Hematology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Clinical Chemistry
6.2.4.1. Clinical Chemistry Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Molecular Diagnostics
6.2.5.1. Molecular Diagnostics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.6. Coagulation
6.2.6.1. Coagulation Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.7. Microbiology
6.2.7.1. Microbiology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.8. Others
6.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. In-Vitro Diagnostics Market By Application
7.1. Introduction
7.2. In-Vitro Diagnostics Revenue By Application
7.2.1. In-Vitro Diagnostics Revenue (USD Billion) and Forecast, By Application, 2018-2030
7.2.2. Infectious Disease
7.2.2.1. Infectious Disease Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Diabetes
7.2.3.1. Diabetes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.4. Oncology
7.2.4.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.5. Cardiology
7.2.5.1. Cardiology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.6. Nephrology
7.2.6.1. Nephrology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.7. Autoimmune Disease
7.2.7.1. Autoimmune Disease Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.8. Drug testing
7.2.8.1. Drug testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.9. Others
7.2.9.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. In-Vitro Diagnostics Market By End-Use
8.1. Introduction
8.2. In-Vitro Diagnostics Revenue By End-Use
8.2.1. In-Vitro Diagnostics Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
8.2.2. Hospitals
8.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.3. Laboratories
8.2.3.1. Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.4. Home Care
8.2.4.1. Home Care Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.5. Others
8.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 9. North America In-Vitro Diagnostics Market By Country
9.1. North America In-Vitro Diagnostics Market Overview
9.2. U.S.
9.2.1. U.S. In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
9.2.2. U.S. In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
9.2.3. U.S. In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
9.2.4. U.S. In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Canada
9.3.1. Canada In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
9.3.2. Canada In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
9.3.3. Canada In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
9.3.4. Canada In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. North America PEST Analysis
CHAPTER 10. Europe In-Vitro Diagnostics Market By Country
10.1. Europe In-Vitro Diagnostics Market Overview
10.2. U.K.
10.2.1. U.K. In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
10.2.2. U.K. In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.2.3. U.K. In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
10.2.4. U.K. In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Germany
10.3.1. Germany In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
10.3.2. Germany In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.3.3. Germany In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
10.3.4. Germany In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. France
10.4.1. France In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
10.4.2. France In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.4.3. France In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
10.4.4. France In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Spain
10.5.1. Spain In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
10.5.2. Spain In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.5.3. Spain In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
10.5.4. Spain In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.6. Rest of Europe
10.6.1. Rest of Europe In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
10.6.2. Rest of Europe In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.6.3. Rest of Europe In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
10.6.4. Rest of Europe In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific In-Vitro Diagnostics Market By Country
11.1. Asia Pacific In-Vitro Diagnostics Market Overview
11.2. China
11.2.1. China In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
11.2.2. China In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.2.3. China In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
11.2.4. China In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. Japan
11.3.1. Japan In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
11.3.2. Japan In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.3.3. Japan In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
11.3.4. Japan In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. India
11.4.1. India In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
11.4.2. India In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.4.3. India In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
11.4.4. India In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Australia
11.5.1. Australia In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
11.5.2. Australia In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.5.3. Australia In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
11.5.4. Australia In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.6. South Korea
11.6.1. South Korea In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
11.6.2. South Korea In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.6.3. South Korea In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
11.6.4. South Korea In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
11.7.2. Rest of Asia-Pacific In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.7.3. Rest of Asia-Pacific In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
11.7.4. Rest of Asia-Pacific In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America In-Vitro Diagnostics Market By Country
12.1. Latin America In-Vitro Diagnostics Market Overview
12.2. Brazil
12.2.1. Brazil In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
12.2.2. Brazil In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
12.2.3. Brazil In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
12.2.4. Brazil In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.3. Mexico
12.3.1. Mexico In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
12.3.2. Mexico In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
12.3.3. Mexico In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
12.3.4. Mexico In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.4. Rest of Latin America
12.4.1. Rest of Latin America In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
12.4.2. Rest of Latin America In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
12.4.3. Rest of Latin America In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
12.4.4. Rest of Latin America In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa In-Vitro Diagnostics Market By Country
13.1. Middle East & Africa In-Vitro Diagnostics Market Overview
13.2. GCC
13.2.1. GCC In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
13.2.2. GCC In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
13.2.3. GCC In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
13.2.4. GCC In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.3. South Africa
13.3.1. South Africa In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
13.3.2. South Africa In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
13.3.3. South Africa In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
13.3.4. South Africa In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Product, 2018-2030
13.4.2. Rest of Middle East & Africa In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Technology, 2018-2030
13.4.3. Rest of Middle East & Africa In-Vitro Diagnostics Revenue (USD Billion) and Forecast By Application, 2018-2030
13.4.4. Rest of Middle East & Africa In-Vitro Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of In-Vitro Diagnostics Market
14.1. In-Vitro Diagnostics Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global In-Vitro Diagnostics Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Abbott
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2021
15.1.3.2. Abbott 2021 In-Vitro Diagnostics Business Regional Distribution
15.1.4. Product/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Becton
15.3. Dickinson and Company
15.4. bioMérieux SA
15.5. Bio-Rad Laboratories, Inc.
15.6. Danaher (Beckman Coulter, Inc.)
15.7. F. Hoffmann-La Roche AG
15.8. Siemens
15.9. QIAGEN
15.10. Sysmex
15.11. Thermo Fisher Scientific
Frequently Asked Questions
What is the size of global in-vitro diagnostics market in 2021?
The estimated value of global in-vitro diagnostics market in 2021 was accounted to be USD 83.3 Billion.
What is the CAGR of global in-vitro diagnostics market during forecast period of 2022 to 2030?
The projected CAGR in-vitro diagnostics market during the analysis period of 2022 to 2030 is 3.2%.
Which are the key players operating in the market?
The prominent players of the global in-vitro diagnostics market are Abbott, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens, QIAGEN, Sysmex, and Thermo Fisher Scientific.
Which region held the dominating position in the global in-vitro diagnostics market?
North America held the dominating in-vitro diagnostics during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for in-vitro diagnostics during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global in-vitro diagnostics market?
Rising elderly population and consequent increase in chronic and communicable diseases incidence drives the growth of global in-vitro diagnostics market.
By application segment, which sub-segment held the maximum share?
Based on application, infectious disease segment is expected to hold the maximum share in-vitro diagnostics market.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
